BRIEF-Gilead COO says slowdown in patients starting hep C therapies to continue in 2017 By: Reuters: Company News January 09, 2017 at 14:49 PM EST * Gilead exec says slowdown in patients starting hepatitis c therapies to continue in 2017 Read More >> Related Stocks: Gilead Sciences